YOLFTbeta
00

Sam-A Pharm. Co. Ltd

009300 · KQ · Healthcare / Pharmaceuticals

13,020.00KRW+90.00 (+0.70%)

Price History

Full chart

Market Stats

Previous Close12,930.00
Open12,930.00
Day Range12,900.00 – 13,070.00
52-Week Range11,950.00 – 16,770.00
Volume1.93K
Market Cap85.26B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield4.99%
Beta0.62
50-Day Avg13,531.80
200-Day Avg14,782.65

About

Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, ant-analgesics, gastro-intestinal, topical, oral, and anti-histamines. It also provides NOMA MEGAFFECT for stress relief, eye care, memory and blood lipid concentration enhancement, endurance enhancement, and the supply of vitamins and minerals; and NOMA-F gummy, NOMA CHEWABLE tablet, and NOMA GOLD chewable tablet for growth promotion, enhancement of nutritional deficiency, and supply of vitamins. Sam-A Pharm. Co., Ltd was founded in 1945 and is based in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOHeo Jun
  • Employees271
  • HeadquartersSAMA Building, Seoul, South Korea, Korea
  • Websitehttps://www.samapharm.co.kr

Leadership

  • Heo JunChief Exec. Officer · b. 1971
  • Hyeon-Wu LeeManaging Director · b. 1960
  • Shin-Jun KangManaging Director · b. 1965
  • Kuk-Hwan ChoiManaging Director · b. 1964
  • Hyeong-Cheol NamManaging Director · b. 1960

Financials

Income Statement

Currency: KRW2009-12-312010-12-312011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue53.09B54.74B56.86B56.57B56.78B59.66B65.88B61.79B66.95B71.56B53.65B54.67B81.70B97.21B95.58B77.80B
Growth (%)-+3.10%+3.87%-0.50%+0.36%+5.08%+10.42%-6.20%+8.34%+6.89%-25.02%+1.89%+49.45%+18.99%-1.68%-18.60%
Cost of Revenue20.88B22.78B21.68B20.92B21.94B23.15B25.38B23.52B26.13B27.88B21.28B22.01B31.54B35.59B34.75B31.44B
Gross Profit32.22B31.96B35.18B35.65B34.84B36.51B40.49B38.28B40.82B43.68B32.37B32.66B50.16B61.62B60.83B46.36B
Gross Margin60.68%58.39%61.87%63.02%61.36%61.20%61.47%61.94%60.97%61.05%60.33%59.74%61.40%63.39%63.64%59.59%
Operating Expense28.07B28.36B27.60B26.38B29.03B30.72B30.91B30.74B31.46B33.29B28.44B26.61B31.91B38.12B36.36B35.38B
Operating Income4.15B3.61B7.57B9.27B5.81B5.79B9.58B7.53B9.36B10.40B3.93B6.05B18.25B23.50B24.47B10.98B
Operating Margin7.82%6.59%13.32%16.39%10.24%9.71%14.54%12.19%13.98%14.53%7.33%11.06%22.34%24.17%25.60%14.11%
EBITDA------------21.65B32.59B34.07B21.28B
EBITDA Margin------------26.50%33.53%35.65%27.35%
Net Income3.51B23.00B9.82B11.95B8.07B7.16B9.87B5.80B8.80B10.20B123.85M3.39B11.91B21.37B22.08B12.94B
Net Income Margin6.60%42.03%17.27%21.12%14.21%12.00%14.98%9.39%13.15%14.25%0.23%6.20%14.58%21.99%23.10%16.63%
R&D1.90B2.16B3.05B3.85B4.49B4.90B4.24B4.51B4.89B5.39B3.68B3.83B3.77B6.40B5.42B6.14B
R&D as % of Total Revenue3.59%3.94%5.37%6.80%7.92%8.21%6.43%7.30%7.30%7.53%6.86%7.00%4.62%6.58%5.67%7.89%
Interest Expense0000000000202.94M125.61M63.43M219.74M538.22M441.06M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.38%0.23%0.08%0.23%0.56%0.57%

Balance Sheet

Currency: KRW2009-12-312010-12-312011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets111.10B128.75B137.86B144.79B145.86B152.91B162.27B167.97B173.69B190.78B182.11B189.17B203.20B231.31B248.73B247.04B
Total Liabilities31.18B26.76B27.28B23.46B11.71B12.83B13.36B11.86B12.78B22.63B15.82B17.15B22.58B30.84B28.76B18.93B
Total Equity79.92B101.99B110.58B121.33B134.15B140.08B148.92B156.10B160.90B168.15B166.29B172.02B180.62B200.47B219.98B228.11B
Cash13.02B16.01B8.24B655.20M3.05B17.50B21.75B9.77B22.42B12.99B18.39B3.84M5.13M9.02B2.56M6.58B
Total Debt---------6.73B5.42B-----

Cash Flow

Currency: KRW2009-12-312010-12-312011-12-312012-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.33B5.10B10.47B14.00B11.38B10.81B10.53B5.10B12.76B13.22B9.41B12.94B19.60B20.76B25.25B10.72B
Investing Cash Flow-4.68B6.82B-16.92B-17.95B-3.42B5.08B-4.96B-15.55B1.42B-21.97B-197.94M-19.80B-13.03B-20.81B-21.41B-
Financing Cash Flow19.40B-8.92B-1.32B-3.63B-9.83B-1.43B-1.32B-1.53B-1.53B-677.18M-3.67B-3.67B-5.38B-111.77M-3.52B-
Capital Expenditure17.64B3.14B843.76M5.26B1.80B3.03B1.16B3.68B2.40B491.74M679.52M275.44M239.25M3.82B6.51B1.78B
Free Cash Flow----------8.73B12.67B19.37B16.94B18.74B8.94B
Dividends Paid598.36M915.50M1.22B1.22B1.22B1.22B1.22B1.53B1.53B1.53B1.83B1.83B1.53B2.44B4.58B4.88B
FCF to OCF----------92.78%97.87%98.78%81.60%74.21%83.41%
Dividend Paid to FCF----------20.98%14.45%7.88%14.41%24.43%54.59%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual208.00222.70-20.85164.6090.69178.29-205.283582.81275.44371.92332.15629.77490.54707.37299.59460.51431.01209.36191.15346.08429.46371.18159.10362.17414.81187.54134.08436.69483.86471.87252.50408.47301.71363.0026.42259.48483.56355.08160.98442.41395.85454.18314.39511.26220.63-60.58-110.65-29.11-69.9927.02101.28497.37521.31112.17676.26641.911114.27907.81668.25811.671534.051040.13344.63698.821029.43441.17-8.86658.38365.32712.97
Surprise----------------------------------------------------------------------
Timing----------------------------------------------------------------------

Key Statistics & Ratios

Market Cap85.26B
Enterprise Value-5.69B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.18
Price / Book0.37
Revenue (TTM)75.48B
Gross Profit (TTM)32.66B
EBITDA20.70B
Profit Margin14.61%
Operating Margin22.65%
Return on Equity890.40%
Return on Assets5.66%
Shares Outstanding6.10M
Shares Float1.93M
Beta0.62
Dividend Yield4.99%
Dividend Rate0.00
Payout Ratio49.20%

Dividends

20251×
850.00Dec 29, 2025
20241×
800.00Dec 27, 2024
20231×
750.00Dec 27, 2023
20221×
400.00Dec 28, 2022
20211×
250.00Dec 29, 2021
20201×
300.00Dec 29, 2020
20191×
300.00Dec 27, 2019
20181×
250.00Dec 27, 2018
20171×
250.00Dec 27, 2017
20161×
250.00Dec 28, 2016
20151×
200.00Dec 29, 2015
20141×
200.00Dec 29, 2014
20131×
200.00Dec 27, 2013
20121×
200.00Dec 27, 2012
20111×
200.00Dec 28, 2011
20101×
200.00Dec 29, 2010
20091×
150.00Dec 29, 2009
20081×
100.00Dec 29, 2008
20071×
196.07Dec 27, 2007
20061×
196.07Dec 27, 2006
20051×
196.07Dec 28, 2005
20041×
196.07Dec 29, 2004
20031×
196.07Dec 29, 2003
20021×
58.82Dec 27, 2002

Stock Splits

  • Dec 29, 20081119:1097